VISIONEERING TECHNOLOGIES INC (VTI)
Share Price Analysis and Chart
Enter the company code or Name for stock analysis:
VTI - VISIONEERING TECHNOLOGIES INC
FNArena Sector :
Medical Equipment & Devices
Year End: December
GICS Industry Group : Health Care Equipment & Services
Debt/EBITDA: -0.48
Index:
FNArena Sector : Medical Equipment & Devices
Year End: December
GICS Industry Group : Health Care Equipment & Services
Debt/EBITDA: -0.48
Visioneering Technologies is headquartered in Alpharetta, Georgia, USA and specialises in design, sale and distribution of NaturalVue contact lenses.
| LAST PRICE | CHANGE +/- | CHANGE % | VOLUME |
|---|---|---|---|
|
$0.165
17 Apr |
OPEN $0.18 |
HIGH $0.18 |
83,434 LOW $0.17 |
-0.010| OTHER COMPANIES IN THE SAME SECTOR | |||
| 4DX . AT1 . BRN . CAT . CBL . CGS . CMP . COH . CSX . CU6 . CYC . EBR . EMV . EYE . FPH . IDX . IME . IMR . IPD . LDX . MX1 . NAN . ONE . PCK . PEB . PGC . PME . RMD . SOM . TRJ . UBI . VHT . | |||
FNARENA'S MARKET CONSENSUS FORECASTS
- No Record -
HISTORICAL DATA ARE ALL IN AUD
Copyright © 2024 FactSet UK Limited. All rights reserved
| Title | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| EPS Basic | xxx | xxx | xxx | xxx | xxx | - |
| DPS All | xxx | xxx | xxx | xxx | xxx | 0.0 |
| Sales/Revenue | xxx | xxx | xxx | xxx | xxx | 13.1 M |
| Book Value Per Share | xxx | xxx | xxx | xxx | xxx | - |
| Net Operating Cash Flow | xxx | xxx | xxx | xxx | xxx | -5.4 M |
| Net Profit Margin | xxx | xxx | xxx | xxx | xxx | - |
EPS Basic
DPS All
Sales/Revenue
Book Value Per Share
Net Operating Cash Flow
Net Profit Margin
| Title | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Return on Capital Employed | xxx | xxx | xxx | xxx | xxx | - |
| Return on Invested Capital | xxx | xxx | xxx | xxx | xxx | - |
| Return on Assets | xxx | xxx | xxx | xxx | xxx | - |
| Return on Equity | xxx | xxx | xxx | xxx | xxx | - |
| Return on Total Capital | xxx | xxx | xxx | xxx | xxx | - |
| Free Cash Flow ex dividends | xxx | xxx | xxx | xxx | xxx | - |
Return on Capital Employed
Return on Invested Capital
Return on Assets
Return on Equity
Return on Total Capital
Free Cash Flow ex dividends
| Title | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Short-Term Debt | xxx | xxx | xxx | xxx | xxx | - |
| Long Term Debt | xxx | xxx | xxx | xxx | xxx | - |
| Total Debt | xxx | xxx | xxx | xxx | xxx | - |
| Goodwill - Gross | xxx | xxx | xxx | xxx | xxx | - |
| Cash & Equivalents - Generic | xxx | xxx | xxx | xxx | xxx | 4 M |
| Price To Book Value | xxx | xxx | xxx | xxx | xxx | - |
Short-Term Debt
Long Term Debt
Total Debt
Goodwill - Gross
Cash & Equivalents - Generic
Price To Book Value
| Title | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Capex | xxx | xxx | xxx | xxx | xxx | - |
| Capex % of Sales | xxx | xxx | xxx | xxx | xxx | - |
| Cost of Goods Sold | xxx | xxx | xxx | xxx | xxx | - |
| Selling, General & Admin. Exp & Other | xxx | xxx | xxx | xxx | xxx | - |
| Research & Development | xxx | xxx | xxx | xxx | xxx | - |
| Investments - Total | xxx | xxx | xxx | xxx | xxx | - |
Capex
Capex % of Sales
Cost of Goods Sold
Selling, General & Admin. Exp & Other
Research & Development
Investments - Total
EXPERT VIEWS
Display All Commentary
Sentiment Indicator
No. Of Recommendations
VTI STOCK CHART
FNArena News on VTI
| 1 |
Australian Broker Call *Extra* Edition – Oct 11, 2021Oct 11 2021 - Daily Market Reports |
| 2 |
Australian Broker Call *Extra* Edition – Sep 17, 2021Sep 17 2021 - Daily Market Reports |
| 3 |
Australian Broker Call *Extra* Edition – Oct 28, 2020Oct 28 2020 - Daily Market Reports |
| 4 |
The Wrap: Regional Banks & Financial AdviceMay 26 2017 - Weekly Reports |
Latest Medical Equipment & Devices News
| 1 |
Uptrend Resumed For ResMedMar 19 2024 - Technicals |
| 2 |
Dr Boreham’s Crucible: CochlearFeb 28 2024 - Australia |
| 3 |
Rudi Interviewed: Ongoing Potential In Technology & GrowthFeb 19 2024 - Rudi's View |
| 4 |
Dr Boreham’s Crucible: ArtryaFeb 15 2024 - Small Caps |
| 5 |
ResMed Recovery Turns Into Hollywood ScriptJan 31 2024 - Australia |
| 6 |
ResMed Makes A ComebackJan 29 2024 - Australia |
| 7 |
ResMed: The Recovery Has BegunJan 23 2024 - Technicals |
| 8 |
Dr Boreham’s Crucible: Pro MedicusOct 23 2023 - Australia |
| 9 |
Dr Boreham’s Crucible: CyclopharmOct 09 2023 - Small Caps |
| 10 |
Dr Boreham’s Crucible: PainchekSep 11 2023 - Small Caps |